WEGOVY .25 mg/.5mL (Semaglutide INJECTION, SOLUTION) .25 mg/.5mL

Wegovy (semaglutide) is a subcutaneous injection solution used for weight management. This 0.25 mg/0.5 mL formulation is designed to support individuals in their weight loss journey. Learn more about Wegovy's uses and effects.

Strength

.25 mg/.5mL

Pack Size

4 SYRINGE, PLASTIC in 1 CARTON (0169-4525-94) / .5 mL in 1 SYRINGE, PLASTIC (0169-4525-90)

Manufacturer / TM Owner

Novo Nordisk

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Wegovy, containing semaglutide, is primarily used for weight management in adults with obesity or overweight with weight-related conditions. It works by mimicking natural hormones to regulate appetite and food intake. Many people wonder, 'What is Wegovy used for?'—it's often part of a broader weight management plan that includes diet and exercise.

Side Effects

Common effects of Wegovy may include nausea, diarrhea, constipation, and injection site reactions. These effects can vary from person to person. It's important to monitor how your body responds to the medication and consult a healthcare provider if you experience persistent or severe symptoms.

Precautions & Warnings

Wegovy should be stored at room temperature and protected from light. Always use a new needle for each injection to prevent contamination. It's crucial to follow proper disposal guidelines for used syringes. If you have a history of thyroid tumors or pancreatitis, discuss this with your healthcare provider before using Wegovy.

Avoid Interactions

Wegovy may interact with certain medications, including those that affect the stomach or intestines. It's important to inform your healthcare provider about all medications you are taking. Additionally, alcohol consumption should be moderated while using Wegovy, as it may exacerbate certain side effects.

Frequently Asked Questions

Wegovy is used for weight management in adults with obesity or overweight with weight-related conditions.

Wegovy is administered via subcutaneous injection, typically in the abdomen, thigh, or upper arm.

Common side effects include nausea, diarrhea, constipation, and injection site reactions.

Consult your healthcare provider before combining Wegovy with other weight loss medications.

Wegovy should be stored at room temperature and protected from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.